For the study, researchers conducted the disinfection technique and monitored its impact on C. diff infection rates over a one-year period (February 2014 to January 2015) across three hematology-oncology units at the Hospital of the University of Pennsylvania in Philadelphia.
The addition of UV disinfection to infection prevention protocols was associated with a 25 percent reduction in C. diff infection rates among new patients in the three study units. Concurrently, C. diff rates increased by 16 percent in units outside of the study.
“These findings have real implications for both health systems and patients,” said David Pegues, MD, lead author of the study and a professor of Medicine in the Perelman School of Medicine at the University of Pennsylvania. “The effectiveness and efficiency of UV-C robots make it a practical and cost effective technology that will benefit hospitals around the country and save people’s lives.”
More articles on infection control:
Illinois hotel potential source for Legionnaires’ outbreak
Vitamin E may reduce risk of pneumonia in elderly men
Bloodstream infection clusters across 3 states may be associated with central lines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
